Safety and Efficacy Evaluation of the Mosaic Ultra Device

Inclusion Criteria:

• Non-smoking, Male or Female
• Age 18 - 60 years old
• Understands and accepts the obligation not to undergo any other procedures in theareas to be treated.
• Participants who are willing and able to comply with all study participationrequirements including returning for follow-up visits and abstaining from exclusionaryprocedures for the duration of the study.
• OPTIONAL - Participants who are willing to undergo biopsies.

Exclusion Criteria:

• Previous surgical or cosmetic procedure to the target area in the last 6 to 12 monthsthat could interfere with the treatment procedure
• A study participant must not be pregnant or have been pregnant in the last 3 months
• A recent history of smoking (6 months)
• Presence of an active skin disease or condition that may affect wound healing (ie.diabetes myelitis; connective tissue disease; radiation therapy; or chemotherapy)
• Seizure disorder caused by bright light
• A history of thrombophlebitis
• A history of acute infections
• A history of heart failure
• Cancer, malignant disease, skin pathology, condition, or allergic reactions that couldinterfere with evaluation or with the use of typical ancillary medical treatments orcare used before, during, or after treatments
• Received or is anticipated to receive antiplatelets, anticoagulants, thrombolytics,vitamin E, or anti-inflammatories within 2 weeks prior to treatment
• Intolerance or allergy to medications that could be prescribed before or after theprocedure (eg, antibiotics, anesthesia)
• A history of keloids
• A history or evidence of poor wound healing
• A history of coagulative disorder or current use of anticoagulant drugs within 2 weeksof study participation
• Use of steroids within 2 weeks of study treatments
• Patients with implanted pacemaker or defibrillator, or metal pins, or prostheticjoints within 4 cm of treatment area
• History of psychoneurosis and/or a history of alcohol or drug abuse